Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Patt · SciRah

Researcher profile · Semantic Scholar

D. Patt

Share profile

D. Patt — researcher profile on SciRah

h-index: 37
Works: 185
Citations: 9,282

Most-cited papers

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
P. Schmid, J. Cortés, R. Dent, L. Pusztai +26 more
2022New England Journal of Medicine956 citations Open access
Semantic Scholar
MONARCH 1, a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR+/HER2− metastatic breast cancer
M. Dickler, S. Tolaney, H. Rugo, J. Cortés +10 more
2017Clinical Cancer Research614 citations Open access
Semantic Scholar
Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors
D. Patt, L. Gordan, Michael Diaz, T. Okon +6 more
2020JCO Clinical Cancer Informatics548 citations Open access
Semantic Scholar
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Miguel Martín, F. Holmes, B. Ejlertsen, S. Delaloge +496 more
2017The Lancet Oncology512 citations
Semantic Scholar
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update.
S. Giordano, S. Temin, S. Chandarlapaty, J. Crews +11 more
2018Journal of Clinical Oncology213 citations
Semantic Scholar
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
A. Chan, B. Moy, J. Mansi, B. Ejlertsen +27 more
2020Clinical Breast Cancer202 citations Open access
Semantic Scholar
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
S. Giordano, M. Franzoi, S. Temin, C. Anders +10 more
2022Journal of Clinical Oncology148 citations Open access
Semantic Scholar
FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer.
M. Oliveira, C. Saura, P. Nuciforo, I. Calvo +12 more
2019Annals of Oncology126 citations Open access
Semantic Scholar
Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.
Cheng-Yue Wu, G. Lorenzo, D. Hormuth, Ernesto A. B. F. Lima +7 more
2022Biophysical Reviews125 citations Open access
Semantic Scholar
Telehealth in Oncology: ASCO Standards and Practice Recommendations
R. Zon, E. Kennedy, K. Adelson, S. Blau +11 more
2021JCO Oncology Practice105 citations Open access
Semantic Scholar
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study
S. Tolaney, K. Kalinsky, V. Kaklamani, D. D'Adamo +14 more
2021Clinical Cancer Research101 citations
Semantic Scholar
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
N. Ramakrishna, S. Temin, S. Chandarlapaty, J. Crews +11 more
2018Journal of Clinical Oncology94 citations
Semantic Scholar
Management of Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Guideline Update
N. Ramakrishna, C. Anders, N. Lin, A. Morikawa +10 more
2022Journal of Clinical Oncology92 citations Open access
Semantic Scholar
Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities
Angela M. Jarrett, D. Faghihi, D. Hormuth, Ernesto A. B. F. Lima +4 more
2020Journal of Clinical Medicine88 citations Open access
Semantic Scholar
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer
N. Denduluri, G. Lyman, Yunfei Wang, P. K. Morrow +11 more
2018Clinical Breast Cancer83 citations Open access
Semantic Scholar
Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
J. Crawford, N. Denduluri, D. Patt, X. Jiao +4 more
2019Supportive Care in Cancer74 citations Open access
Semantic Scholar
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care
N. Pennell, Melissa S. Dillmon, Laura A. Levit, E. Moushey +44 more
2020Journal of Clinical Oncology69 citations
Semantic Scholar
Implementation of Electronic Patient-Reported Outcomes for Symptom Monitoring in a Large Multisite Community Oncology Practice: Dancing the Texas Two-Step Through a Pandemic.
D. Patt, L. Wilfong, K. Hudson, A. Patel +6 more
2021JCO Clinical Cancer Informatics66 citations Open access
Semantic Scholar
Repeatability, Reproducibility, and Accuracy of Quantitative MRI of the Breast in the Community Radiology Setting
A. Sorace, Cheng-Yue Wu, Stephanie L. Barnes, Angela M. Jarrett +8 more
2018Journal of Magnetic Resonance Imaging50 citations Open access
Semantic Scholar
Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data
Angela M. Jarrett, D. Hormuth, Cheng-Yue Wu, A. Kazerouni +9 more
2020Neoplasia48 citations Open access
Semantic Scholar
Tenets for implementing electronic patient-reported outcomes (ePROs) for remote symptom monitoring during cancer treatment
E. Basch, G. Rocque, G. Mody, Samyukta Mullangi +1 more
2023JCO Clinical Cancer Informatics45 citations Open access
Semantic Scholar
Patient-Reported Outcomes, Digital Health, and the Quest to Improve Health Equity.
J. Pritchett, D. Patt, G. Thanarajasingam, Anne L. R. Schuster +1 more
2023American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting44 citations
Semantic Scholar
Quantitative magnetic resonance imaging and tumor forecasting of breast cancer patients in the community setting
Angela M. Jarrett, A. Kazerouni, Cheng-Yue Wu, John Virostko +8 more
2021Nature Protocols42 citations Open access
Semantic Scholar
Telemedicine in Community Cancer Care: How Technology Helps Patients With Cancer Navigate a Pandemic
D. Patt, L. Wilfong, Sara Toth, S. Broussard +10 more
2021JCO Oncology Practice42 citations Open access
Semantic Scholar
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
F. Holmes, B. Moy, S. Delaloge, S. Chia +23 more
2023European Journal of Cancer33 citations Open access
Semantic Scholar
A Randomized Control Trial of Meditation Compared to Music Listening to Improve Cognitive Function for Breast Cancer Survivors: Feasibility and Acceptability
Ashley M. Henneghan, H. Becker, M. Harrison, Kelly Inselmann +5 more
2020Complementary Therapies in Clinical Practice29 citations Open access
Semantic Scholar
Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity
Nathan D. Seligson, J. Warner, W. Dalton, David Martin +14 more
2020J. Am. Medical Informatics Assoc.29 citations Open access
Semantic Scholar
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes
N. Robert, H. Goertz, P. Chopra, X. Jiao +3 more
2017Drugs - Real World Outcomes28 citations Open access
Semantic Scholar
A phase Ib/II study of eribulin (ERI) plus pembrolizumab (PEMBRO) in metastatic triple-negative breast cancer (mTNBC) (ENHANCE 1).
S. Tolaney, K. Kalinsky, V. Kaklamani, D. D'Adamo +13 more
202027 citations
Semantic Scholar
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database Analysis.
D. Patt, Xian-Chen Liu, Benjamin Li, L. McRoy +2 more
2022Clinical Breast Cancer25 citations
Semantic Scholar
Math, magnets, and medicine: enabling personalized oncology
D. Hormuth, Angela M. Jarrett, G. Lorenzo, Ernesto A. B. F. Lima +4 more
2021Expert Review of Precision Medicine and Drug Development23 citations Open access
Semantic Scholar
Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology.
Ravi B. Parikh, Andrew S. Gdowski, D. Patt, A. Hertler +2 more
2019American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting23 citations
Semantic Scholar
The Road of Mentorship.
Kelly J. Cooke, D. Patt, R. Prabhu
2017American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting23 citations
Semantic Scholar
Telemedicine for cancer care: implementation across a multicenter community oncology practice.
D. Patt, L. Wilfong, Kristen Kanipe, R. S. Paulson
2020American Journal of Managed Care22 citations Open access
Semantic Scholar
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis
John Virostko, A. Hainline, Hakmook Kang, L. Arlinghaus +8 more
2017Journal of Medical Imaging20 citations Open access
Semantic Scholar
The Road of Mentorship.
Kelly J. Cooke, D. Patt, R. Prabhu
2017American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting16 citations
Semantic Scholar
Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
John Virostko, A. Sorace, Kalina P. Slavkova, A. Kazerouni +7 more
2021Breast Cancer Research14 citations Open access
Semantic Scholar
Clinical Challenges and Opportunities With Current Electronic Health Records: Practicing Oncologists' Perspective.
D. Patt, P. Stella, L. Bosserman
2018Journal of Oncology Practice10 citations Open access
Semantic Scholar
Abstract GS1-01: KEYNOTE-522 study of neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses
P. Schmid, J. Cortés, R. Dent, L. Pusztai +26 more
2022Cancer Research9 citations
Semantic Scholar
Considerations to increase rates of breast cancer screening across populations.
D. Patt, L. Gordan, K. Patel, T. Okon +6 more
2022American Journal of Managed Care8 citations Open access
Semantic Scholar
Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1
H. Rugo, V. Diéras, J. Cortés, D. Patt +13 more
2020Breast Cancer Research and Treatment8 citations Open access
Semantic Scholar
Abstract CT044: MONARCH 1: Final overall survival analysis of a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, as monotherapy, in patients with HR+/HER2- breast cancer, after chemotherapy for advanced disease
H. Rugo, S. Tolaney, J. Cortés, V. Diéras +6 more
20178 citations
Semantic Scholar
Using Clinical Informatics to Navigate a Crisis: How Technology and Policy Change Can Influence Cancer Care Delivery.
D. Patt
2020JCO Clinical Cancer Informatics7 citations Open access
Semantic Scholar
Magnetization Transfer MRI of Breast Cancer in the Community Setting: Reproducibility and Preliminary Results in Neoadjuvant Therapy
John Virostko, A. Sorace, Cheng-Yue Wu, David A. Ekrut +6 more
2019Tomography7 citations Open access
Semantic Scholar
201P Trilaciclib combined with sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC): Preliminary phase II results
L. Seneviratne, K. Harnden, M. Mardones, S. Blau +12 more
2023ESMO Open6 citations Open access
Semantic Scholar
Analysis of Simplicial Complexes to Determine When to Sample for Quantitative DCE-MRI of the Breast
J. DiCarlo, Angela M. Jarrett, A. Kazerouni, John Virostko +7 more
2022Magnetic Resonance in Medicine5 citations Open access
Semantic Scholar
Cancer Informatics in 2019: Deep Learning Takes Center Stage
J. Warner, D. Patt
2020Yearbook of Medical Informatics5 citations Open access
Semantic Scholar
Abstract CT041: Primary results from FAIRLANE (NCT02301988), a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) + paclitaxel (PAC) for early triple-negative breast cancer (eTNBC)
M. Oliveira, C. Saura, I. Calvo, J. Andersen +13 more
2018Clinical Trials5 citations
Semantic Scholar
Machine Learning and Real-World Data: More than Just Buzzwords.
Z. Bakouny, D. Patt
2021JCO Clinical Cancer Informatics4 citations
Semantic Scholar
Abstract PD3-03: Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: Final overall survival analysis from the randomized phase 3 ExteNET trial
F. Holmes, B. Moy, S. Delaloge, S. Chia +20 more
2021Poster Spotlight Session Abstracts4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Yankeelov×10
Invite
T. Yankeelov — researcher profile on SciRah
John Virostko×9
Invite
John Virostko — researcher profile on SciRah
Angela M. Jarrett×8
Invite
Angela M. Jarrett — researcher profile on SciRah
A. Sorace×7
Invite
A. Sorace — researcher profile on SciRah

×7

Invite

Sarah Avery — researcher profile on SciRah

Invite

B. Goodgame — researcher profile on SciRah

N. Denduluri×6

Invite

N. Denduluri — researcher profile on SciRah

Cheng-Yue Wu×6

Invite

Cheng-Yue Wu — researcher profile on SciRah

Invite

J. Cortés — researcher profile on SciRah

Invite

S. Tolaney — researcher profile on SciRah

J. Perlmutter×5

Invite

J. Perlmutter — researcher profile on SciRah

Invite

D. Hormuth — researcher profile on SciRah